MICB and Merkel cell skin cancer: Furthermore, the introduction of histone deacetylase inhibitors to MCC cells both in vitro and in vivo reversed the epigenetic silencing of MICA and MICB, resulting in increased susceptibility of MCC cells to immune-mediated tumor lysis [112,119].